AXGN as of Oct 31 · 16:53 ET
AXGNNasdaqElectromedical & Electrotherapeutic Apparatus
Axogen, Inc. · Brief
Next report
72 days
Jan 11 · before openest.Q4 FY26
Expected move
Inputs3 of 8≥ implied
- avg implied
- ±16.0%
- avg realized
- ±13.5%
May 8 '25±14.1%▼−23.18%×1.65
Aug 5 '25±22.3%▲+9.32%×0.42
Oct 29 '25±16.5%▲+23.06%×1.40
Jan 12 '26±10.5%▼−5.85%×0.56
Feb 24 '26±13.3%▼−8.14%×0.61
Q1 FY26±15.4%▲+6.60%×0.43
Q2 FY26±16.1%▲+0.53%×0.03
Q3 FY26±19.5%▲+31.47%×1.62
quarterimplied−35%0+35%realized×
Q3 FY26±19.5%▲+31.47%×1.62
Q2 FY26±16.1%▲+0.53%×0.03
Q1 FY26±15.4%▲+6.60%×0.43
Feb '26±13.3%▼−8.14%×0.61
Jan '26±10.5%▼−5.85%×0.56
Oct '25±16.5%▲+23.06%×1.40
2 older reports
Aug '25±22.3%▲+9.32%×0.42
May '25±14.1%▼−23.18%×1.65
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Jan 11 report · est.—
Linked exposure
AXGN report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.